Direct answer
Healthcare interoperability strategy succeeds when standards are paired with an operating model: shared governance, identity, terminology, workflow ownership, testing, incentives and accountability for what happens after data moves. FHIR, APIs and national roadmaps matter, but they do not replace the work of changing how organizations make decisions together.
This article is educational analysis for digital health leaders, product teams and implementation partners. It is not clinical, legal, regulatory, privacy or procurement advice. Any interoperability programme that touches patient data, clinical workflows or regulated products needs qualified local review.
The current policy direction is clear. WHO describes digital health scale-up as requiring standards, architecture and strong governance. HL7 presents FHIR as a standard for exchanging healthcare information electronically. CMS and ONC continue to push API-based exchange, network alignment and modern health-data infrastructure. The practical problem is that many organizations adopt the language of interoperability before they have built the management system that makes it reliable.
A standard is not a service
A standard defines how data can be represented or exchanged. A service defines who needs the data, why they need it, when it should arrive, what quality is acceptable and who acts when the exchange fails. Confusing the two creates expensive disappointment. Teams announce interoperability because an endpoint exists, then clinicians discover that the information is incomplete, duplicated, late or hard to reconcile inside the workflow.
FHIR is a major improvement for implementation because it gives teams common resources, APIs and implementation patterns. But a technically valid FHIR exchange can still fail operationally. The patient may not be matched correctly. Terminology may not map cleanly. Consent rules may differ across organizations. A receiving team may not know who is responsible for acting on the result. These are operating-model questions, not merely interface questions.
Leaders should therefore ask a blunt question before funding another integration: what decision or action will improve when this data becomes available? If the answer is only "we will have access," the strategy is not finished. Access has value when it changes scheduling, medication reconciliation, prior authorization, care coordination, analytics, patient communication or safety monitoring in a defined way.
Build the operating model around six jobs
The first job is governance. Someone must decide which data-sharing use cases matter most, which standards are required, how exceptions are handled and how conflicts are resolved. Governance should include clinical operations, architecture, privacy, security, data governance, product and frontline representation. If it sits only in IT, it will miss workflow reality. If it sits only in policy, it will miss implementation constraints.
The second job is identity and matching. Interoperability depends on knowing whose data is being exchanged and under what authority. Patient matching, provider identity, organization identity, role-based access and auditability are not afterthoughts. Weak identity controls turn technically connected systems into unsafe systems.
The third job is terminology. Exchanging data is easier than making data mean the same thing. Labs, medications, conditions, procedures, observations and documents need agreed vocabularies, mapping rules and exception handling. Without terminology governance, downstream analytics and clinical displays can become misleading even when transport works.
The fourth job is workflow design. A care manager, pharmacist, clinician, payer reviewer or patient-facing app may all consume the same exchange differently. The operating model should define what arrives, where it appears, who triages it, how duplicates are handled and what escalation exists when something is missing.
The fifth job is assurance. Conformance testing checks whether a system follows a technical specification. Operational testing checks whether the exchange works under real load, real exceptions and real user behaviour. Both are needed. A pilot that passes a scripted demo may still fail when records are incomplete, networks are slow or staff have no time to reconcile incoming information.
The sixth job is lifecycle management. Standards evolve, implementation guides change, policy requirements shift and products are upgraded. Interoperability is not a one-time integration project. It needs release management, regression testing, monitoring, incident response and funding for maintenance.
Give workflow owners real authority
Healthcare interoperability often fails at the handoff between architecture and daily work. The data arrives, but nobody owns the queue. A result is visible, but not in the screen where the clinician makes the decision. A payer receives structured information, but still requests documents because internal policy has not changed. A patient can download records, but cannot use them to complete the next task.
Workflow owners should be named for each use case. For medication reconciliation, that may include pharmacy, clinical operations and health information management. For appointment or encounter data, it may include scheduling, care coordination and patient communication. For population analytics, it may include data governance, public health and quality improvement. The point is to make accountability visible before the interface goes live.
Good workflow ownership also prevents over-sharing. More data is not always better. Teams should define the minimum useful information, the timing, the display context and the action path. That keeps exchange aligned with safety, privacy and usability rather than turning interoperability into a flood of unactioned records.
Test the messy parts, not only the happy path
A mature interoperability programme tests identity uncertainty, incomplete records, conflicting terminology, consent withdrawal, stale documents, unavailable endpoints, duplicate patients, missing attachments and user workload. These scenarios reveal whether the operating model works. They also help teams decide which failures should block go-live and which can be monitored after release.
Metrics should include more than transaction counts. Track successful matches, failed matches, average response time, duplicate rate, missing-field rate, manual reconciliation time, user-reported issues, incident volume and whether the exchanged data changed the intended decision. A dashboard that celebrates API traffic while ignoring clinical usefulness creates a false sense of progress.
Evidence should be staged. Early work may prove that two systems can exchange a defined payload. The next stage should prove that the data is trusted and usable in workflow. Larger scale should require evidence on safety, equity, privacy, operational burden and sustainability. This is consistent with WHO's broader digital-health governance emphasis: digital systems should be integrated, sustainable and oriented toward health-system value.
Align incentives, contracts and governance
Interoperability is partly technical and partly political. Organizations may say they support data sharing while their incentives reward retention, manual review or proprietary workflows. Contracts may mention standards but omit service levels, testing responsibilities, audit support, change management and exit rights. Governance should surface those tensions early.
Procurement language should require standards compliance, implementation-guide alignment, test evidence, data-export rights, monitoring, incident support, privacy obligations and cooperation during transitions. It should also avoid impossible promises. No vendor can make a fragmented ecosystem interoperable alone. The buyer must define the operating model and hold participants to it.
Commercial incentives should be reviewed alongside technical requirements. A product team may support export but make configuration costly. A provider group may want outside records but lack staffing to triage them. A payer may request structured documentation but keep a manual exception process that weakens the benefit. Interoperability strategy should name these friction points instead of assuming that policy language will remove them.
Contracts can make cooperation measurable. Require implementation documentation, sandbox access, change notices, downtime communication, audit logs, test participation and a clear process for disputed data quality. These clauses will not solve governance by themselves, but they give operational teams something concrete to enforce when a connection stops working as expected.
Equity also belongs in the operating model. Patient-facing exchange should account for language, accessibility, delegated caregivers, people without reliable devices and people who move between systems often. Staff-facing exchange should account for workload and training. An interoperable system that helps only highly resourced users may be technically connected while still failing the population it was meant to serve.
Finally, make the review cycle explicit. The steering group should know when a use case will be revisited, which incidents trigger escalation and which metrics would justify expanding, pausing or retiring the exchange. Without that loop, interoperability becomes an accumulation of interfaces. With it, the programme can learn which connections are improving care coordination and which are only adding technical maintenance, visibly and accountably.
The strongest strategy treats interoperability as a shared capability. Architecture teams keep standards coherent. Clinical and operational teams own workflows. Privacy and security teams define guardrails. Product teams design usable handoffs. Executives fund maintenance and make trade-offs visible. Regulators and national bodies set direction where they have authority, but local implementation still determines whether data helps people at the point of care.
For related analysis, read mHealth Zone on prioritizing digital health investments and the governance gap between pilots and infrastructure. Interoperability is not won by naming the right standard. It is won by making connected work safe, usable and governable.
FAQ
Is FHIR enough for healthcare interoperability?
No. FHIR is an important exchange standard, but organizations still need governance, identity, terminology, workflow redesign, testing and policy alignment.
Who should own interoperability strategy?
Ownership should combine executive sponsorship, clinical operations, technical architecture, privacy, security, data governance and frontline workflow representation.
Is this clinical or regulatory advice?
No. This article is educational analysis and should be reviewed by qualified clinical, regulatory, privacy and legal teams before implementation decisions.
Sources consulted: WHO digital health overview, WHO strategy and governance, HL7 FHIR overview, CMS interoperability work, ONC nationwide interoperability roadmap. Featured image: existing site asset, /assets/img/photo-section.jpg.